Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort study.

IF 10.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Diabetology Pub Date : 2025-02-07 DOI:10.1186/s12933-025-02611-0
Qi Huang, Xiantong Zou, Zhouhui Lian, Xianghai Zhou, Xueyao Han, Yingying Luo, Shuohua Chen, Yanxiu Wang, Shouling Wu, Linong Ji
{"title":"Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort study.","authors":"Qi Huang, Xiantong Zou, Zhouhui Lian, Xianghai Zhou, Xueyao Han, Yingying Luo, Shuohua Chen, Yanxiu Wang, Shouling Wu, Linong Ji","doi":"10.1186/s12933-025-02611-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular complications are major concerns for Chinese patients with type 2 diabetes. Accurately predicting these risks remains challenging due to limitations in traditional risk models. We aimed to develop a dynamic prediction model using machine learning and longitudinal trajectories of cardiovascular risk factors to improve prediction accuracy.</p><p><strong>Methods: </strong>We included 16,378 patients from the Kailuan cohort, splitting them into training and testing datasets. Using baseline characteristics and changes over a four-year observation period, we developed the ML-CVD-C (Machine Learning Cardiovascular Disease in Chinese) score to predict 10-year cardiovascular risk, including cardiovascular death, nonfatal myocardial infarction, and stroke. We compared the discrimination and calibration of ML-CVD-C with models using only baseline variables (ML-CVD-C [base]), China-PAR (Prediction for ASCVD Risk in China), and PREVENT (Predict Risk of cardiovascular disease EVENTs). Risk stratification improvements were assessed through net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Transition analysis examined the changes in risk stratification over time.</p><p><strong>Results: </strong>The ML-CVD-C score achieved a C-index of 0.80 (95% CI: 0.78-0.82) in the testing cohort, significantly outperforming the ML-CVD-C (base) score, China-PAR, and PREVENT, which had C-index values of 0.62-0.65. ML-CVD-C also provided more accurate cardiovascular risk estimates, though all models tended to overestimate the prevalence of high-risk cases. Stratification by the ML-CVD-C score showed substantial improvement, with NRI gains of 57.7%, 44.1%, and 47.3%, and IDI gains of 10.1%, 7.9%, and 8.4% compared to the other three scores. Both the trajectory and machine learning algorithm contributed significantly to the enhancement of model performance. Transition analysis revealed that participants who remained in the same risk category or were reclassified to a lower category exhibited 22% and 86% reductions in cardiovascular risk compared to those reclassified to a higher risk category during the observation period.</p><p><strong>Conclusions: </strong>The ML-CVD-C model, incorporating dynamic cardiovascular risk trajectories and a machine learning algorithm, significantly improves risk prediction accuracy for Chinese patients with diabetes. This model may serve as a valuable tool for more personalized cardiovascular risk management in type 2 diabetes.</p>","PeriodicalId":9374,"journal":{"name":"Cardiovascular Diabetology","volume":"24 1","pages":"61"},"PeriodicalIF":10.6000,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11806858/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Diabetology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12933-025-02611-0","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiovascular complications are major concerns for Chinese patients with type 2 diabetes. Accurately predicting these risks remains challenging due to limitations in traditional risk models. We aimed to develop a dynamic prediction model using machine learning and longitudinal trajectories of cardiovascular risk factors to improve prediction accuracy.

Methods: We included 16,378 patients from the Kailuan cohort, splitting them into training and testing datasets. Using baseline characteristics and changes over a four-year observation period, we developed the ML-CVD-C (Machine Learning Cardiovascular Disease in Chinese) score to predict 10-year cardiovascular risk, including cardiovascular death, nonfatal myocardial infarction, and stroke. We compared the discrimination and calibration of ML-CVD-C with models using only baseline variables (ML-CVD-C [base]), China-PAR (Prediction for ASCVD Risk in China), and PREVENT (Predict Risk of cardiovascular disease EVENTs). Risk stratification improvements were assessed through net reclassification improvement (NRI) and integrated discrimination improvement (IDI). Transition analysis examined the changes in risk stratification over time.

Results: The ML-CVD-C score achieved a C-index of 0.80 (95% CI: 0.78-0.82) in the testing cohort, significantly outperforming the ML-CVD-C (base) score, China-PAR, and PREVENT, which had C-index values of 0.62-0.65. ML-CVD-C also provided more accurate cardiovascular risk estimates, though all models tended to overestimate the prevalence of high-risk cases. Stratification by the ML-CVD-C score showed substantial improvement, with NRI gains of 57.7%, 44.1%, and 47.3%, and IDI gains of 10.1%, 7.9%, and 8.4% compared to the other three scores. Both the trajectory and machine learning algorithm contributed significantly to the enhancement of model performance. Transition analysis revealed that participants who remained in the same risk category or were reclassified to a lower category exhibited 22% and 86% reductions in cardiovascular risk compared to those reclassified to a higher risk category during the observation period.

Conclusions: The ML-CVD-C model, incorporating dynamic cardiovascular risk trajectories and a machine learning algorithm, significantly improves risk prediction accuracy for Chinese patients with diabetes. This model may serve as a valuable tool for more personalized cardiovascular risk management in type 2 diabetes.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结合危险因素轨迹和机器学习算法预测中国2型糖尿病患者心血管结局:一项队列研究
背景:心血管并发症是中国2型糖尿病患者关注的主要问题。由于传统风险模型的局限性,准确预测这些风险仍然具有挑战性。我们的目标是利用机器学习和心血管危险因素的纵向轨迹建立一个动态预测模型,以提高预测的准确性。方法:我们纳入了来自开滦队列的16,378例患者,将其分为训练和测试数据集。利用基线特征和四年观察期的变化,我们开发了ML-CVD-C(机器学习心血管疾病)评分来预测10年心血管风险,包括心血管死亡、非致死性心肌梗死和中风。我们比较了ML-CVD-C与仅使用基线变量(ML-CVD-C [base])、China- par(预测中国ASCVD风险)和PREVENT(预测心血管疾病事件风险)的模型的区分和校准。通过净再分类改善(NRI)和综合歧视改善(IDI)评估风险分层改善。过渡分析检查了风险分层随时间的变化。结果:在测试队列中,ML-CVD-C评分的c指数为0.80 (95% CI: 0.78-0.82),显著优于ML-CVD-C(基础)评分、China-PAR和PREVENT的c指数为0.62-0.65。ML-CVD-C也提供了更准确的心血管风险估计,尽管所有模型都倾向于高估高危病例的患病率。ML-CVD-C评分的分层显示出实质性的改善,与其他三个评分相比,NRI增加了57.7%,44.1%和47.3%,IDI增加了10.1%,7.9%和8.4%。轨迹和机器学习算法都对模型性能的增强有显著贡献。过渡分析显示,在观察期间,与重新分类为高风险类别的参与者相比,保持相同风险类别或被重新分类为较低类别的参与者的心血管风险降低了22%和86%。结论:ML-CVD-C模型结合了动态心血管风险轨迹和机器学习算法,显著提高了中国糖尿病患者风险预测的准确性。该模型可作为2型糖尿病患者更个性化的心血管风险管理的有价值的工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Diabetology
Cardiovascular Diabetology 医学-内分泌学与代谢
CiteScore
12.30
自引率
15.10%
发文量
240
审稿时长
1 months
期刊介绍: Cardiovascular Diabetology is a journal that welcomes manuscripts exploring various aspects of the relationship between diabetes, cardiovascular health, and the metabolic syndrome. We invite submissions related to clinical studies, genetic investigations, experimental research, pharmacological studies, epidemiological analyses, and molecular biology research in this field.
期刊最新文献
Stress hyperglycemia ratio in coronary artery disease: a systematic review and meta-analysis of severity and prognosis. The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Timing-dependent anti-inflammatory effects of empagliflozin in monocyte-derived macrophages from post-myocardial infarct patients with type 2 diabetes. The shared genetic architecture underlying the autoimmune and cardiovascular disease: a multivariate genome-wide analysis. Causal demonstration of adiposity-induced adipose-specific signaling derangements in the pathogenesis of the clinical features of the cardiovascular-kidney metabolic syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1